Lithium Controlled-Release and Extended-Release Tablets and Tobi inhalation
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Tobi inhalation and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: tobramycin
Brand name: Bethkis, Kitabis Pak, Tobi, TOBI Podhaler
Synonyms: Tobi (inhalation), Tobi
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-TOBI Podhaler
- Lithium Controlled-Release and Extended-Release Tablets-Tobi Podhaler inhalation
- Lithium Controlled-Release and Extended-Release Tablets-Tobradex
- Lithium Controlled-Release and Extended-Release Tablets-TobraDex (Tobramycin and Dexamethasone Eye Drops)
- Lithium Controlled-Release and Extended-Release Tablets-TobraDex (Tobramycin and Dexamethasone Eye Ointment)
- Lithium Controlled-Release and Extended-Release Tablets-TobraDex Eye Drops
- Tobi inhalation-Lithium ER
- Tobi inhalation-Lithium Oral Solution
- Tobi inhalation-Lithium Salts
- Tobi inhalation-Lithium Syrup and Oral Solution
- Tobi inhalation-Lithobid
- Tobi inhalation-Lithostat